DYEE Capital Overview
- Investor Type
-
Venture Capital
- Investments
-
68
- Portfolio
-
48
- Exits
-
12
DYEE Capital General Information
Company Description
Founded in June 2016, DYEE Capital is an early and growth stage venture capital firm based in Xiamen, China. The firm has also invested in private equity opportunities and seeks to make investments in sectors such as information services, consumption, medical and healthcare.
Business Details
Website
www.dyeecapital.comYear Founded
Primary Investor Type
Other Investor Types
Corporate Office
- V7, Haiyuan Villa, Haiyue Shanzhuang
- No. 3999 Huandao South Road, Siming District
- Xiamen, Fujian
- China
DYEE Capital Investments (68)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Genedock | 03-Jan-2024 | Later Stage VC | Database Software | Generating Revenue | ||
| Jiangsu Vcare | 03-Jan-2024 | Drug Discovery | Clinical Trials - General | |||
| Asia Regenerative Medicine | 20-Nov-2023 | Laboratory Services (Healthcare) | Pre-Clinical Trials | |||
| YL-Pharma | 08-Nov-2023 | Drug Discovery | Generating Revenue | |||
| TenaFe | 24-Oct-2023 | General Purpose Semiconductors | Generating Revenue | |||
| Genepoint | 18-Jan-2023 | Drug Delivery | Generating Revenue | |||
| Genfleet | 21-Dec-2022 | Drug Discovery | Clinical Trials - General | |||
| Yunyin Technology | 18-Nov-2022 | Printing Services (B2B) | Generating Revenue | |||
| WeLion New Energy | 04-Nov-2022 | Later Stage VC | Electrical Equipment | Generating Revenue | ||
| MaxiNovel Pharmaceuticals | 18-Oct-2022 | Later Stage VC | Drug Discovery | Clinical Trials - General |
DYEE Capital Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| InventisBio | 25-Jul-2022 | IPO | |
| Zongmu | 01-May-2022 | ||
| Zongmu | 01-Jun-2021 | ||
| Zongmu | 01-Feb-2021 | ||
| Allist Pharmaceuticals | 02-Dec-2020 | IPO | |
| Mengdao Technology | 09-Jan-2020 | Out of Business |
DYEE Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
DYEE Capital Co-Investors (122)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| CDH Investments | 3 |
|
|
||
| Lapam Capital |
|
|
|||
| Cowin Capital |
|
|
|||
| Fortune Capital |
|
|
|||
| Shenzhen Capital Group |
|
|
DYEE Capital FAQs
-
What is DYEE Capital?
Founded in June 2016, DYEE Capital is an early and growth stage venture capital firm based in Xiamen, China.
-
When was DYEE Capital founded?
DYEE Capital was founded in 2016.
-
Where is DYEE Capital headquartered?
DYEE Capital is headquartered in Xiamen, China.
-
How many investments has DYEE Capital made?
DYEE Capital has made 68 investments.
-
What has DYEE Capital invested in?
DYEE Capital has made numerous investments in companies like Genedock, Jiangsu Vcare, and Asia Regenerative Medicine within the Database Software, Drug Discovery, and Laboratory Services (Healthcare) industries.
-
What has DYEE Capital invested in recently?
DYEE Capital's latest investment was on 03-Jan-2024 in Genedock, a company within the Database Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
